$6.99
arrow_drop_down4.24%Key Stats | |
---|---|
Open | $7.29 |
Prev. Close | $7.23 |
EPS | -7.89 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $150.39M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 7.15 | 7.49 |
52 Week Range | 6.38 | 29.70 |
Ratios | |
---|---|
EPS | -7.89 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
What's in Store for ADMA Biologics (ADMA) in Q2 Earnings? - Zacks Investment Research
Adverum biotechnologies executive buys shares worth over $1.7 million By Investing.com - Investing.com Australia
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Adverum Biotechnologies Presents Positive Ixo-vec Clinical - GlobeNewswire
Down -19.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?